BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
16 results:

  • 1. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
    AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
    Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options.
    Tlemsani C; Leroy K; Gimenez-Roqueplo AP; Mansuet-Lupo A; Pasmant E; Larousserie F; Boudou-Rouquette P; Vidaud M; Cadranel J; Blons H; Goldwasser F; Laurent-Puig P
    J Med Genet; 2020 Feb; 57(2):104-108. PubMed ID: 30352869
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.
    Dogan A; Kern P; Schultheis B; Häusler G; Rezniczek GA; Tempfer CB
    BMC Cancer; 2018 Apr; 18(1):463. PubMed ID: 29690864
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
    Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
    J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
    Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
    PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genital Cancers in Women: Uterine Cancer.
    Roett MA
    FP Essent; 2015 Nov; 438():11-7. PubMed ID: 26569046
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
    Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
    J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.
    Grzankowski KS; Shimizu DM; Kimata C; Black M; Terada KY
    Gynecol Oncol; 2012 Sep; 126(3):408-12. PubMed ID: 22617524
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
    de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
    Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.
    Agarwalla PK; Dunn IF; Turner CD; Ligon KL; Schneider KA; Smith ER
    Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome.
    Levi Z; Hazazi R; Kedar-Barnes I; Hodak E; Gal E; Mor E; Niv Y; Winkler J
    Am J Transplant; 2007 Feb; 7(2):476-9. PubMed ID: 17229076
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of DNA mismatch repair proteins hMSH2 and hmlh1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy.
    Idikio HA
    Oncol Rep; 2001; 8(5):965-71. PubMed ID: 11496300
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models.
    Middlemas DS; Stewart CF; Kirstein MN; Poquette C; Friedman HS; Houghton PJ; Brent TP
    Clin Cancer Res; 2000 Mar; 6(3):998-1007. PubMed ID: 10741727
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.